Viridian Therapeutics Inc... (VRDN)
14.40
-1.13 (-7.28%)
At close: Mar 03, 2025, 3:59 PM
14.41
0.03%
After-hours: Mar 03, 2025, 04:54 PM EST
Viridian Therapeutics Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -237.73M | -129.87M | -79.41M | -110.72M | -41.87M | -32.7M | -26.51M | -12.67M | -11.33M | -7.89M | -2.16M | -5.62M |
| Depreciation & Amortization | 522K | 255K | 120K | 239K | 288K | 281K | 308K | 189K | 184K | 144K | 148.31K | 144.29K |
| Stock-Based Compensation | 67.17M | 19.77M | 14.46M | 3.65M | 3.97M | 3.68M | 2.41M | 2.11M | 3.02M | 4.3M | n/a | 7.96K |
| Other Working Capital | 2.62M | 4.44M | 69K | 4.75M | 1.21M | 58.64M | 47.97M | 161K | -220K | -185K | -384.2K | -110.33K |
| Other Non-Cash Items | -4.71M | 54K | 7.49M | 72.57M | 340K | 376K | 94K | 93K | 132K | 953K | 1.49M | 2.49M |
| Deferred Income Tax | n/a | n/a | 1.04M | 56K | -432K | -416K | n/a | 868K | n/a | 177K | n/a | -1.64M |
| Change in Working Capital | -9.43M | 15.96M | 1.72M | 4.43M | 1.65M | 1.94M | -4.47M | 2.18M | 1.1M | 105K | -649.45K | -1.61M |
| Operating Cash Flow | -184.17M | -93.84M | -54.58M | -29.78M | -36.06M | -26.84M | -28.17M | -7.23M | -6.9M | -2.21M | -1.17M | -6.22M |
| Capital Expenditures | -898K | -797K | -338K | -42K | -84K | -445K | -246K | -3K | -123K | -266K | -4.77K | -106.91K |
| Acquisitions | n/a | 114.33M | 79K | 29.37M | -28.31M | n/a | 1.28M | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -407.88M | -223.26M | -188.43M | -81.81M | -32.69M | -62.46M | n/a | -1M | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | 314.53M | 108.94M | 114.4M | 2M | 61M | 33M | n/a | 1M | 50K | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -114.33M | -73.95M | -3K | 28.31M | -29.46M | 1.28M | n/a | 28K | -8K | 10.45K | -12.52K |
| Investing Cash Flow | -94.25M | -115.13M | -74.29M | -50.48M | 28.23M | -29.91M | 1.03M | -3K | -95K | -274K | 5.68K | -119.43K |
| Debt Repayment | 15M | 5M | n/a | -8.57M | -2.33M | n/a | 5.33M | -333K | -76K | 753K | 2.04M | 6.58M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -173K | -363K | n/a | -500K | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -285K | -720K |
| Other Financial Acitivies | 85.6M | 43.55M | 16.96M | 84.77M | -77K | -2.61M | -1.43M | 76K | 50K | n/a | -78 | -50K |
| Financial Cash Flow | 225.67M | 322.24M | 125.28M | 101.31M | 70K | 41.92M | 52.47M | -257K | 12.71M | 7.4M | 1.26M | 5.81M |
| Net Cash Flow | -52.75M | 113.28M | -3.6M | 21.05M | -7.76M | -14.84M | 25.34M | -7.49M | 5.71M | 4.91M | 96.81K | -538.66K |
| Free Cash Flow | -185.07M | -94.64M | -54.92M | -29.82M | -36.14M | -27.29M | -28.41M | -7.23M | -7.02M | -2.48M | -1.17M | -6.33M |